Professional Documents
Culture Documents
a
M. Adeel Razzaq
b
Nayya Waseem Dar
Ph.D. Biochemist
a HEC Research Scholar
• “Drug is any substance that when taken into the living organism may modify one or more of its
functions”.
• Drug discovery in the past often resulted from observations of the effects of plant extracts or individual
chemicals on animals or humans with no knowledge of the drug’s mechanism or site of action
• Antimicrobial agents were viewed as miracle cures when first introduced into clinical practice
• After the discovery of penicillin, resistance develops and dims the luster of the miracle
• This serious development is ever present with each new antimicrobial agent
• Today, every major class of antibiotic is associated with the emergence of significant
resistance
Drug Resistance
Drug Resistance
• Some microbes are inherently resistant to certain AMAs • Some microbes develop resistant strains due to use of
• They lack the metabolic process or the target site which AMAs over period of time
is affected by the drugs • Some of these strains may even become resistant to
• E.g., Gram negative bacilli are unaffected by penicillin G more than one antibiotic
• Mutation
Genetic Alteration
• Gene transfer
Mutation
• Resistance developed by mutation is stable and heritable genetic changes that occur spontaneously and
randomly among microorganisms
3) Protein involved in drug transport 4) Protein important for drug activation or inactivation
• Multistep gene may modify the more number of genes and decrease the sensitivity of AMAs to pathogens
Mechanism of Drug Resistance
(Genetic Alteration)
Gene Transfer
a) Transformation
b) Transduction
c) Conjugation
Mechanism of Drug Resistance
(Gene Transfer)
Transformation
cross-over mechanism
Transduction
through bacteriophage
Conjugation
• Cell to cell contact; transfer of chromosomal and extrachromosomal DNA from one bacterium to another
through sex pili.
• Gene carrying the resistance or “R” factor is transferred only if another “resistant transfer factor (RTF) is
present.
• Conjugation may frequently occur in colon, here large variety of Gram-negative bacilli come in close
contact.
• Chloramphenicol resistance to typhoid bacilli and streptomycin resistance to E. coli and many others have
been traced to this mechanism.
Mechanism of Drug Resistance
(Altered Expression of Protein)
Decreased Accumulation
• Decreased uptake or increased efflux of an antibiotic can confer resistance
• For example, gram-negative organisms can limit the penetration of certain agents, including β-lactam
antibiotics
Mechanism of Drug Resistance
(Altered Expression of Protein)
Enzymatic Inactivation
• The ability to destroy or inactivate the antimicrobial agent can also confer resistance on microorganisms.
3 Types
1. Chromosome-mediated resistance
2. Plasmid-mediated resistance
3. Transposons-mediated resistance
Genetic Determinants
of Drug Resistance
Chromosome-mediated resistance
1) the target of drug or 2) the transport system in the membrane of the cell wall
Plasmid-mediated resistance
Transposons-mediated resistance
• “Transposons are repetitive DNA sequences that have the capability to move (transpose) from one
location to another in genome”.
• Transposons can transfer from a plasmid to other plasmids or from a DNA chromosome to plasmid and
vice versa that cause the transmission of antibiotic resistance genes in bacteria.
• Transposons are unable to replicate independently, some may replicate during the process of integration
Transposons-mediated resistance
• Antimicrobial categories are classifications of antimicrobial agents based on their mode of action and
specific to targe organisms
❑ Bacteria
❑ Viruses
❑ Enzymatic degradation
❑ Decreased accumulation
❑ Efflux pump
Common MDROs
❑ MDR-TB
MRSA
❑ Methicillin
❑ Oxacillin
❑ Nafcillin
• Most S. aureus skin infections, including MRSA, appear as a bump or infected area on the skin that
might be:
❑ Red
❑ Swollen
❑ Painful
❑ Accompanied by a fever
ESBLs
• “XDR was defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial
categories”
• Initially, the term XDR was created to describe extensively drug-resistant Mycobacterium tuberculosis
(XDR MTB) and was defined as ‘resistance to the first-line agents isoniazid and rifampicin, to a
fluoroquinolone and to at least one of the three-second-line parenteral drugs (i.e. amikacin, kanamycin
or capreomycin)’
XDR-TB
• “Pandrug resistance was defined as non-susceptibility to all agents in all antimicrobial categories”
Preventive Measures
• To limit the development of MDR & XDR, it has been suggested to:
❑ Use the appropriate antimicrobial for an infection; e.g. no antibiotics for viral infections
❑ Select an antimicrobial which targets the specific organism, rather than relying on a broad-spectrum antimicrobial
❑ Complete an appropriate duration of antimicrobial treatment (not too short and not too long)
THANK YOU!